Genetic expression and mutational profile analysis in different pathologic stages of hepatocellular carcinoma patients
Open Access
- 8 July 2021
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 21 (1) , 1-15
Abstract
Background: The clinical pathologic stages (stage I, II, III-IV) of hepatocellular carcinoma (HCC) are closely linked to the clinical prognosis of patients. This study aims at investigating the gene expression and mutational profile in different clinical pathologic stages of HCC. Methods: Based on the TCGA-LIHC cohort, we utilized a series of analytical approaches, such as statistical analysis, random forest, decision tree, principal component analysis (PCA), to identify the differential gene expression and mutational profiles. The expression patterns of several targeting genes were also verified by analyzing the Chinese HLivH060PG02 HCC cohort, several GEO datasets, HPA database, and diethylnitrosamine-induced HCC mouse model. Results: We identified a series of targeting genes with copy number variation, which is statistically associated with gene expression. Non-synonymous mutations mainly existed in some genes (e.g.,TTN, TP53, CTNNB1). Nevertheless, no association between gene mutation frequency and pathologic stage distribution was detected. The random forest and decision tree modeling analysis data showed a group of genes related to different HCC pathologic stages, including GAS2L3 and SEMA3F. Additionally, our PCA data indicated several genes associated with different pathologic stages, including SNRPA and SNRPD2. Compared with adjacent normal tissues, we observed a highly expressed level of GAS2L3, SNRPA, and SNRPD2 (P = 0.002) genes in HCC tissues of our HLivH060PG02 cohort. We also detected the high expression pattern of GAS2L3, SEMA3F, SNRPA, and SNRPD2 in the datasets of GSE102079, GSE76427, GSE64041, GSE121248, GSE84005, and the qPCR assay using diethylnitrosamine-induced HCC mouse model. Moreover, SEMA3F and SNRPD2 protein were highly stained in the HCC tissues of the HPA database. The high expression level of these four genes was associated with the poor survival prognosis of HCC cases. Conclusions: Our study provides evidence regarding the gene expression and mutational profile in different clinical pathologic stages of TCGA HCC cases. Identifying four targeting genes, including GAS2L3, SNRPA, SNRPD2, and SEMA3F, offers insight into the molecular mechanisms associated with different prognoses of HCC.Keywords
This publication has 34 references indexed in Scilit:
- Prognostic genes of hepatocellular carcinoma based on gene coexpression network analysisJournal of Cellular Biochemistry, 2019
- Goals and targets for personalized therapy for HCCHepatology International, 2019
- SNP‐SNP and SNP‐environment interactions of potentially functional HOTAIR SNPs modify the risk of hepatocellular carcinomaMolecular Carcinogenesis, 2018
- Staging systems of hepatocellular carcinoma: A reviewIndian Journal of Gastroenterology, 2018
- SND1 acts as an anti-apoptotic factor via regulating the expression of lncRNA UCA1 in hepatocellular carcinomaRNA Biology, 2018
- Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targetsCancer Genetics, 2017
- Manual evaluation of tissue microarrays in a high‐throughput research project: The contribution of Indian surgical pathology to the Human Protein Atlas (HPA) projectProteomics, 2016
- A Practical Guide to The Cancer Genome Atlas (TCGA)2016
- TNM/Okuda/Barcelona/UNOS/CLIP International Multidisciplinary Classification of Hepatocellular Carcinoma: concepts, perspectives, and radiologic implicationsAbdominal Radiology, 2014
- [19] Gene Expression Omnibus: Microarray Data Storage, Submission, Retrieval, and Analysis2006